{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T19:42:52Z","timestamp":1793216572457,"version":"4.5.0"},"reference-count":105,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,7,2]],"date-time":"2018-07-02T00:00:00Z","timestamp":1530489600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hormones"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1007\/s42000-018-0046-0","type":"journal-article","created":{"date-parts":[[2018,7,2]],"date-time":"2018-07-02T09:14:16Z","timestamp":1530522856000},"page":"351-358","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Endocrine paraneoplastic syndromes in lung cancer"],"prefix":"10.1007","volume":"17","author":[{"given":"Christoforos","family":"Efthymiou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dionisios","family":"Spyratos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore","family":"Kontakiotis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,2]]},"reference":[{"key":"46_CR1","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1097\/00063198-200307000-00012","volume":"9","author":"PJ Mazzone","year":"2003","unstructured":"Mazzone PJ, Arroliga AC (2003) Endocrine paraneoplastic syndromes in lung cancer. Curr Opin Pulm Med 9:313\u2013320","journal-title":"Curr Opin Pulm Med"},{"key":"46_CR2","doi-asserted-by":"publisher","first-page":"838","DOI":"10.4065\/mcp.2010.0099","volume":"85","author":"LC Pelosof","year":"2010","unstructured":"Pelosof LC, Gerber DE (2010) Paraneoplastic syndromes: an approach to diagnosis and treatment. Mayo Clin Proc 85:838\u2013854","journal-title":"Mayo Clin Proc"},{"key":"46_CR3","doi-asserted-by":"publisher","first-page":"149S","DOI":"10.1378\/chest.07-1358","volume":"132","author":"SG Spiro","year":"2007","unstructured":"Spiro SG, Gould MK, Colice GL (2007) Initial evaluation of the patient with lung cancer: symptoms, signs, laboratory tests, and paraneoplastic syndromes: ACCP evidenced-based clinical practice guidelines (2nd edition). Chest 132:149S\u2013160S","journal-title":"Chest"},{"key":"46_CR4","first-page":"584","volume":"93","author":"VCI Carey","year":"1966","unstructured":"Carey VCI (1966) The Incidence of hypercalcemia in association with bronchogenic carcinoma. Am Rev Respir Dis 93:584\u2013586","journal-title":"Am Rev Respir Dis"},{"key":"46_CR5","doi-asserted-by":"publisher","first-page":"205","DOI":"10.7326\/0003-4819-80-2-205","volume":"80","author":"RA Bender","year":"1974","unstructured":"Bender RA, Hansen H (1974) Hypercalcemia in bronchogenic carcinoma. A prospective study of 200 patients. Ann Intern Med 80:205\u2013208","journal-title":"Ann Intern Med"},{"key":"46_CR6","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1002\/cncr.10828","volume":"95","author":"A Hiraki","year":"2002","unstructured":"Hiraki A, Ueoka H, Bessho A et al (2002) Parathyroid hormone-related protein measured at the time of first visit is an indicator of bone metastases and survival in lung carcinoma patients with hypercalcemia. Cancer 95:1706\u20131713","journal-title":"Cancer"},{"key":"46_CR7","first-page":"13091312","volume":"71","author":"R Vassilopoulou-Sellin","year":"1993","unstructured":"Vassilopoulou-Sellin R, Newman BM, Taylor SH et al (1993) Incidence of hypercalcemia in patients with malignancy referred to a comprehensive cancer center. Cancer 71:13091312","journal-title":"Cancer"},{"key":"46_CR8","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1210\/jcem-68-5-976","volume":"68","author":"K Yoshimoto","year":"1989","unstructured":"Yoshimoto K, Yamasaki R, Sakai H et al (1989) Ectopic production of parathyroid hormone by small cell lung cancer in a patient with hypercalcemia. J Clin Endocrinol Metab 68:976\u2013981","journal-title":"J Clin Endocrinol Metab"},{"key":"46_CR9","first-page":"3793","volume":"81","author":"PK Nielsen","year":"1996","unstructured":"Nielsen PK, Rasmussen AK, Feldt-Rasmussen U et al (1996) Ectopic production of intact parathyroid hormone by a squamous cell lung carcinoma in vivo and in vitro. J Clin Endocrinol Metab 81:3793\u20133796","journal-title":"J Clin Endocrinol Metab"},{"key":"46_CR10","first-page":"83","volume":"39","author":"M Lazaretti-Castro","year":"1993","unstructured":"Lazaretti-Castro M, Kayath M, Jamnik S et al (1993) Prevalence of hypercalcemia in patients with lung cancer. Rev Assoc Med Bras 39:83\u201387","journal-title":"Rev Assoc Med Bras"},{"key":"46_CR11","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1097\/MED.0b013e32834b4401","volume":"18","author":"GA Clines","year":"2011","unstructured":"Clines GA (2011) Mechanisms and treatment of hypercalcemia of malignancy. Curr Opin Endocrinol Diabetes Obes 18:339\u2013346","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"46_CR12","first-page":"808","volume-title":"Harrison\u2019s principles of internal medicine","author":"JL Jameson","year":"2008","unstructured":"Jameson JL, Johnson BE (2008) Paraneoplastic syndromes: endrocrinologic\/hematologic. In: Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson JL, Loscalzo J (eds) Harrison\u2019s principles of internal medicine, 17th edn. McGraw Hill, Sudbury, pp 808\u2013824","edition":"17"},{"key":"46_CR13","first-page":"411","volume":"12","author":"D Radulescu","year":"2007","unstructured":"Radulescu D, Pripon S, Bunea D, Ciuleanu TE, Radulescu LI (2007) Endocrine paraneoplastic syndromes in small cell lung carcinoma. Two case reports. J BUON 12:411\u2013414","journal-title":"J BUON"},{"key":"46_CR14","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1056\/NEJMcp042806","volume":"352","author":"AF Stewart","year":"2005","unstructured":"Stewart AF (2005) Clinical practice. Hypercalcemia associated with cancer. N Engl J Med 352:373\u2013379","journal-title":"N Engl J Med"},{"key":"46_CR15","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1056\/NEJMra030831","volume":"350","author":"GD Roodman","year":"2004","unstructured":"Roodman GD (2004) Mechanisms of bone metastasis. N Engl J Med 350:1655\u20131664","journal-title":"N Engl J Med"},{"key":"46_CR16","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s00384-006-0256-9","volume":"23","author":"XT Ma","year":"2008","unstructured":"Ma XT, Yu LW, Fu J (2008) Paraneoplastic syndromes of hypercalcemia and leukocytosis associated with colonic metastases from squamous cell carcinoma of the lung. Int J Colorectal Dis 23:129\u2013130","journal-title":"Int J Colorectal Dis"},{"key":"46_CR17","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1126\/science.3616618","volume":"237","author":"LJ Suva","year":"1987","unstructured":"Suva LJ, Winslow GA, Wettenhall RE, Hammonds RG, Moseley JM, Diefenbach-Jagger H, Rodda CP, Kemp BE, Rodriguez H, Chen EY (1987) A parathyroid hormone-related protein implicated in malignant hypercalcemia: cloning and expression. Science 237:893\u2013896","journal-title":"Science"},{"key":"46_CR18","first-page":"702","volume":"13","author":"A Hussain","year":"2012","unstructured":"Hussain A, Adnan A, El-Hasani S (2012) Small cell carcinoma of the lung presented as acute pancreatitis. Case report and review of the literature. JOP 13:702\u2013704","journal-title":"JOP"},{"key":"46_CR19","first-page":"238","volume-title":"Hematology\/oncology secrets","author":"CH Dolbey","year":"2003","unstructured":"Dolbey CH (2003) Hypercalcemia of malignancy. In: Wood ME, Philips GK (eds) Hematology\/oncology secrets, 3rd edn. Hanley and Belfus, Philadelphia, pp 238\u2013243","edition":"3"},{"key":"46_CR20","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1056\/NEJM200001203420306","volume":"342","author":"GJ Strewler","year":"2000","unstructured":"Strewler GJ (2000) The physiology of parathyroid hormone-related protein. N Engl J Med 342:177\u2013185","journal-title":"N Engl J Med"},{"key":"46_CR21","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1002\/(SICI)1097-0142(19961001)78:7<1384::AID-CNCR3>3.0.CO;2-L","volume":"78","author":"E Takai","year":"1996","unstructured":"Takai E, Yano T, Iguchi H, Fukuyama Y, Yokoyama H, Asoh H, Ichinose Y (1996) Tumor-induced hypercalcemia and parathyroid hormone-related protein in lung carcinoma. Cancer 78:1384\u20131387","journal-title":"Cancer"},{"key":"46_CR22","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/0002-9343(86)90035-5","volume":"80","author":"J Coggeshall","year":"1986","unstructured":"Coggeshall J, Merrill W, Hande K et al (1986) Implications of hypercalcemia with respect to diagnosis and treatment of lung cancer. Am J Med 80:325\u2013328","journal-title":"Am J Med"},{"key":"46_CR23","first-page":"440","volume-title":"Cancer symptom management","author":"MT Richerson","year":"2004","unstructured":"Richerson MT (2004) Electrolyte imbalances. In: Yarbro CH, Frogge MH, Goodman M (eds) Cancer symptom management, 3rd edn. Jones and Bartlett, Sudbury, pp 440\u2013460","edition":"3"},{"key":"46_CR24","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1188\/10.CJON.357-364","volume":"14","author":"MT McClelland","year":"2010","unstructured":"McClelland MT (2010) Paraneoplastic syndromes related to lung cancer. Clin J Oncol Nurs 14:357\u2013364","journal-title":"Clin J Oncol Nurs"},{"key":"46_CR25","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s11864-004-0006-6","volume":"5","author":"L Thomas","year":"2004","unstructured":"Thomas L, Kwok Y, Edelman MJ (2004) Management of paraneoplastic syndromes in lung cancer. Curr Treat Options Oncol 5:51\u201362","journal-title":"Curr Treat Options Oncol"},{"key":"46_CR26","first-page":"791","volume-title":"Cancer nursing: principles and practice","author":"AMK McDonnell Keenan","year":"2005","unstructured":"McDonnell Keenan AMK, Wickham RS (2005) Hypercalcemia. In: Yarbro CH, Frogge MH, Goodman M (eds) Cancer nursing: principles and practice, 6th edn. Jones and Bartlett, Sudbury, pp 791\u2013807","edition":"6"},{"key":"46_CR27","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/sj.bjc.6603828","volume":"97","author":"G Lorch","year":"2007","unstructured":"Lorch G, Gilmore JL, Koltz PF, Gonterman RM, Laughner R, Lewis DA, Konger RL, Nadella KS, Toribio RE, Rosol TJ, Foley J (2007) Inhibition of epidermal growth factor receptor signalling reduces hypercalcaemia induced by human lung squamous-cell carcinoma in athymic mice. Br J Cancer 97:183\u2013193","journal-title":"Br J Cancer"},{"key":"46_CR28","doi-asserted-by":"publisher","first-page":"259","DOI":"10.7326\/0003-4819-149-4-200808190-00007","volume":"149","author":"SB LeGrand","year":"2008","unstructured":"LeGrand SB, Leskuski D, Zama I (2008) Narrative review: furosemide for hypercalcemia: an unproven yet common practice. Ann Intern Med 149:259\u2013263","journal-title":"Ann Intern Med"},{"key":"46_CR29","doi-asserted-by":"publisher","first-page":"205","DOI":"10.2174\/157488709789957718","volume":"4","author":"S Ricciardi","year":"2009","unstructured":"Ricciardi S, de Marinis F (2009) Treatment of bone metastases in lung cancer: the actual role of zoledronic acid. Rev Recent Clin Trials 4:205\u2013211","journal-title":"Rev Recent Clin Trials"},{"key":"46_CR30","first-page":"2249","volume-title":"Harrison\u2019s principles of internal medicine","author":"JT Potts Jr","year":"2005","unstructured":"Potts JT Jr (2005) Diseases of the parathyroid gland and other hyper- and hypocalcemic disorders. In: Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL (eds) Harrison\u2019s principles of internal medicine, 16th edn. Jones and Bartlett, Sudbury, pp 2249\u20132268","edition":"16"},{"key":"46_CR31","unstructured":"Hempill RR (2007) Hypercalcemia. Retrieved from \n                    http:\/\/www.emedicine.com\/emerg\/topic260.htm"},{"key":"46_CR32","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1001\/archinte.1973.03650090019004","volume":"132","author":"OL Silva","year":"1973","unstructured":"Silva OL, Becker KL (1973) Salmon calcitonin in the treatment of hypercalcemia. Arch Intern Med 132:337\u2013339","journal-title":"Arch Intern Med"},{"key":"46_CR33","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1097\/00130404-200601000-00009","volume":"12","author":"F Cvitkovic","year":"2006","unstructured":"Cvitkovic F, Armand JP, Tubiana-Hulin M et al (2006) Randomized, double-blind, phase II trial of gallium nitrate compared with pamidronate for acute control of cancer-related hypercalcemia. Cancer J 12:47\u201353","journal-title":"Cancer J"},{"key":"46_CR34","doi-asserted-by":"publisher","first-page":"5132","DOI":"10.1200\/JCO.2010.29.7101","volume":"28","author":"AT Stopeck","year":"2010","unstructured":"Stopeck AT, Lipton A, Body JJ, Steger GG, Tonkin K, de Boer RH, Lichinitser M, Fujiwara Y, Yardley DA, Viniegra M, Fan M, Jiang Q, Dansey R, Jun S, Braun A (2010) Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study. J Clin Oncol 28:5132\u20135139","journal-title":"J Clin Oncol"},{"key":"46_CR35","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/0002-9343(57)90224-3","volume":"23","author":"WB Schwartz","year":"1957","unstructured":"Schwartz WB, Bennett W, Curelop S et al (1957) A syndrome of renal sodium loss and hyponatremia probably resulting from inappropriate secretion of antidiuretic hormone. Am J Med 23:529\u2013542","journal-title":"Am J Med"},{"key":"46_CR36","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1210\/jcem-28-2-162","volume":"28","author":"H Vorherr","year":"1968","unstructured":"Vorherr H, Massry SG, Utiger RD et al (1968) Antidiuretic principle in malignant tumor extracts from patients with inappropriate ADH syndrome. J Clin Endocrinol Metab 28:162\u2013168","journal-title":"J Clin Endocrinol Metab"},{"key":"46_CR37","doi-asserted-by":"publisher","first-page":"544549","DOI":"10.1056\/NEJM196309122691102","volume":"269","author":"TT Amatruda","year":"1963","unstructured":"Amatruda TT, Mulrow PJ et al (1963) Carcinoma of the lung with inappropriate dieresis. Demonstration of an antidiuretic-like-hormone activity in tumor extract. N Engl J 269:544549","journal-title":"N Engl J"},{"key":"46_CR38","doi-asserted-by":"publisher","first-page":"228","DOI":"10.3121\/cmr.2007.762","volume":"5","author":"AA Onitilo","year":"2007","unstructured":"Onitilo AA, Kio E, Doi SA (2007) Tumor-related hyponatremia. Clin Med Res 5:228\u2013237","journal-title":"Clin Med Res"},{"key":"46_CR39","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1097\/MCP.0b013e328347bdba","volume":"17","author":"SCJ Yeung","year":"2011","unstructured":"Yeung SCJ et al (2011) Lung cancer-induced paraneoplastic syndromes. Curr Opin Pulm Med 17:260\u2013268","journal-title":"Curr Opin Pulm Med"},{"key":"46_CR40","doi-asserted-by":"publisher","first-page":"e121S","DOI":"10.1378\/chest.12-2352","volume":"143","author":"DE Ost","year":"2013","unstructured":"Ost DE, Yeung SC, Tanoue LT, Gould MK (2013) Clinical and organizational factors in the initial evaluation of patients with lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 143:e121S\u2013e141S","journal-title":"Chest"},{"issue":"3","key":"46_CR41","doi-asserted-by":"publisher","first-page":"197","DOI":"10.5306\/wjco.v5.i3.197","volume":"5","author":"N Kanaji","year":"2014","unstructured":"Kanaji N et al (2014) Paraneoplastic syndromes associated with lung cancer. World J Clin Oncol 5(3):197\u2013223","journal-title":"World J Clin Oncol"},{"key":"46_CR42","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1023\/A:1008369932384","volume":"11","author":"SL Vanhees","year":"2000","unstructured":"Vanhees SL, Paridaens R, Vansteenkiste JF (2000) Syndrome of inappropriate antidiuretic hormone associated with chemotherapy-induced tumour lysis in small-cell lung cancer: case report and literature review. Ann Oncol 11:1061\u20131065","journal-title":"Ann Oncol"},{"key":"46_CR43","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1200\/JCO.1986.4.8.1191","volume":"4","author":"AF List","year":"1986","unstructured":"List AF, Hainsworth JD, Davis BW, Hande KR, Greco FA, Johnson DH (1986) The syndrome of inappropriate secretion of antidiuretic hormone (SIADH) in small-cell lung cancer. J Clin Oncol 4:1191\u20131198","journal-title":"J Clin Oncol"},{"key":"46_CR44","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1002\/1097-0142(19830101)51:1<161::AID-CNCR2820510131>3.0.CO;2-P","volume":"51","author":"JD Hainsworth","year":"1983","unstructured":"Hainsworth JD, Workman R, Greco FA (1983) Management of the syndrome of inappropriate antidiuretic hormone secretion in small cell lung cancer. Cancer 51:161\u2013165","journal-title":"Cancer"},{"key":"46_CR45","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1002\/1097-0142(19821115)50:10<2111::AID-CNCR2820501023>3.0.CO;2-O","volume":"50","author":"JJ Lokich","year":"1982","unstructured":"Lokich JJ (1982) The frequency and clinical biology of the ectopic hormone syndromes of small cell carcinoma. Cancer 50:2111\u20132114","journal-title":"Cancer"},{"key":"46_CR46","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1183\/09031936.95.08071231","volume":"8","author":"I Monsieur","year":"1995","unstructured":"Monsieur I, Meysman M, Noppen M, de Greve J, Delhove O, Velckeniers B, Jacobvitz D, Vincken W (1995) Non-small-cell lung cancer with multiple paraneoplastic syndromes. Eur Respir J 8:1231\u20131234","journal-title":"Eur Respir J"},{"key":"46_CR47","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.1136\/pgmj.2005.036889","volume":"81","author":"LM Tho","year":"2005","unstructured":"Tho LM, Ferry DR (2005) Is the paraneoplastic syndrome of inappropriate antidiuretic hormone secretion in lung cancer always attributable to the small cell variety? Postgrad Med J 81:e17","journal-title":"Postgrad Med J"},{"key":"46_CR48","first-page":"279","volume":"6","author":"P McDonald","year":"2012","unstructured":"McDonald P, Lane C, Rojas GE, Masood A (2012) Syndrome of inappropriate anti-diuretic hormone in non-small cell lung carcinoma: a case report. Ecancermedicalscience 6:279","journal-title":"Ecancermedicalscience"},{"key":"46_CR49","first-page":"164e167","volume":"22","author":"L Praneet","year":"2017","unstructured":"Praneet L, Mohammad I (2017) Syndrome of inappropriate secretion of anti-diuretic hormone (SIADH) as an initial presenting sign of non small cell lung cancer-case report and literature review. Respir Med Case Rep 22:164e167","journal-title":"Respir Med Case Rep"},{"key":"46_CR50","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.lungcan.2009.05.015","volume":"68","author":"O Hansen","year":"2010","unstructured":"Hansen O, Sorensen P, Hansen KH (2010) The occurrence of hyponatremia in SCLC and the influence on prognosis : a retrospective study of 453 patients treated in a single institution in a 10-year period. Lung Cancer 68:111\u2013114","journal-title":"Lung Cancer"},{"key":"46_CR51","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1002\/1097-0142(19870901)60:5<1089::AID-CNCR2820600528>3.0.CO;2-U","volume":"60","author":"K Kamoi","year":"1987","unstructured":"Kamoi K, Ebe T, Hasegawa A, Sato F, Takato H, Iwamoto H, Kaneko H, Ishibashi M, Yamaji T (1987) Hyponatremia in small cell lung cancer. Mechanisms not involving inappropriate ADH secretion. Cancer 60:1089\u20131093","journal-title":"Cancer"},{"key":"46_CR52","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1093\/jnci\/82.4.305","volume":"82","author":"DP Bliss","year":"1990","unstructured":"Bliss DP, Battey JF, Linnoila RI, Birrer MJ, Gazdar AF, Johnson BE (1990) Expression of the atrial natriuretic factor gene in small cell lung cancer tumors and tumor cell lines. J Natl Cancer Inst 82:305\u2013310","journal-title":"J Natl Cancer Inst"},{"key":"46_CR53","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1002\/1097-0142(19950515)75:10<2442::AID-CNCR2820751009>3.0.CO;2-Q","volume":"75","author":"BG Campling","year":"1995","unstructured":"Campling BG, Sarda IR, Baer KA, Pang SC, Baker HM, Lofters WS, Flynn TG (1995) Secretion of atrial natriuretic peptide and vasopressin by small cell lung cancer. Cancer 75:2442\u20132451","journal-title":"Cancer"},{"key":"46_CR54","doi-asserted-by":"publisher","first-page":"631","DOI":"10.6004\/jnccn.2006.0052","volume":"4","author":"L Gandhi","year":"2006","unstructured":"Gandhi L, Johnson B (2006) Paraneoplastic syndromes associated with small cell lung cancer. J Natl Compr Cancer Netw 4:631\u2013638","journal-title":"J Natl Compr Cancer Netw"},{"key":"46_CR55","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1056\/NEJM198605083141921","volume":"314","author":"E Cogan","year":"1986","unstructured":"Cogan E, Debi\u00e8ve MF, Philipart I, Pepersack T, Abramow M (1986) High plasma levels of atrial natriuretic factor in SIADH. N Engl J Med 314:1258\u20131259","journal-title":"N Engl J Med"},{"key":"46_CR56","doi-asserted-by":"publisher","first-page":"795","DOI":"10.7326\/0003-4819-105-5-795_2","volume":"105","author":"JE Donckier","year":"1986","unstructured":"Donckier JE, Meunier HT, Ketelslegers JM, Lambert AE (1986) Atrial natriuretic peptide and the syndrome of inappropriate secretion of antidiuretic hormone. Ann Intern Med 105:795\u2013796","journal-title":"Ann Intern Med"},{"key":"46_CR57","first-page":"808","volume-title":"Cancer nursing: principles and practice","author":"TS Armstrong","year":"2005","unstructured":"Armstrong TS (2005) Paraneoplastic syndromes. In: Yarbro CH, Frogge MH, Goodman M (eds) Cancer nursing: principles and practice, 6th edn. Jones and Bartlett, Sudbury, pp 808\u2013824","edition":"6"},{"key":"46_CR58","doi-asserted-by":"publisher","first-page":"282","DOI":"10.3816\/CLC.2007.n.008","volume":"8","author":"P Saintigny","year":"2007","unstructured":"Saintigny P, Chouahnia K, Cohen R, Pailler MC, Brechot JM, Morere JF, Breau JL (2007) Tumor lysis associated with sudden onset of syndrome of inappropriate antidiuretic hormone secretion. Clin Lung Cancer 8:282\u2013284","journal-title":"Clin Lung Cancer"},{"key":"46_CR59","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1007\/s00520-007-0309-9","volume":"15","author":"H Raftopoulos","year":"2007","unstructured":"Raftopoulos H (2007) Diagnosis and management of hyponatremia in cancer patients. Support Care Cancer 15:1341\u20131347","journal-title":"Support Care Cancer"},{"key":"46_CR60","doi-asserted-by":"publisher","first-page":"715","DOI":"10.3949\/ccjm.77a.08051","volume":"77","author":"C Vaidya","year":"2010","unstructured":"Vaidya C, Ho W, Freda BJ (2010) Management of hyponatremia: providing treatment and avoiding harm. Cleve Clin J Med 77:715\u2013726","journal-title":"Cleve Clin J Med"},{"key":"46_CR61","doi-asserted-by":"publisher","first-page":"2723","DOI":"10.1001\/jama.1977.03270520033016","volume":"237","author":"DTA Demeclocycline","year":"1977","unstructured":"Demeclocycline DTA (1977) Treatment for syndrome of inappropriate antidiuretic hormone secretion. JAMA 237:2723\u20132726","journal-title":"JAMA"},{"key":"46_CR62","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/PL00005139","volume":"357","author":"A Tahara","year":"1998","unstructured":"Tahara A, Saito M, Sugimoto T, Tomura Y, Wada K, Kusayama T, Tsukada J, Ishii N, Yatsu T, Uchida W, Tanaka A (1998) Pharmacological characterization of YM087, a potent, nonpeptide human vasopressin V1A and V2 receptor antagonist. Naunyn Schmiedebergs Arch Pharmacol 357:63\u201369","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"46_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1527-3466.2007.00001.x","volume":"25","author":"T Miyazaki","year":"2007","unstructured":"Miyazaki T, Fujiki H, Yamamura Y, Nakamura S, Mori T (2007) Tolvaptan, an orally active vasopressin V(2)-receptor antagonist\u2014pharmacology and clinical trials. Cardiovasc Drug Rev 25:1\u201313","journal-title":"Cardiovasc Drug Rev"},{"key":"46_CR64","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.1093\/annonc\/mdr431","volume":"22","author":"S Kenz","year":"2011","unstructured":"Kenz S, Haas CS, Werth SC, Bohnet S, Brabant G (2011) High sensitivity to tolvaptan in paraneoplastic syndrome of inappropriate ADH secretion (SIADH). Ann Oncol 22:2696","journal-title":"Ann Oncol"},{"key":"46_CR65","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1210\/jcem-22-7-693","volume":"22","author":"CK Meador","year":"1962","unstructured":"Meador CK, Liddle GW, Island DP et al (1962) Cause of Cushing\u2019s syndrome in patients with tumors arising from \u2018nonendocrine\u2019 tissue. J Clin Endocrinol Metab 22:693\u2013703","journal-title":"J Clin Endocrinol Metab"},{"key":"46_CR66","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/BF03347737","volume":"17","author":"RJ Auchus","year":"1994","unstructured":"Auchus RJ, Mastorakos G, Friedman TC, Chrousos GP (1994) Corticotropin-releasing hormone production by a small cell carcinoma in a patient with ACTH-dependent Cushing\u2019s syndrome. J Endocrinol Invest 17:447\u2013452","journal-title":"J Endocrinol Invest"},{"key":"46_CR67","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/1746-1596-5-56","volume":"5","author":"S Shahani","year":"2010","unstructured":"Shahani S, Nudelman RJ, Nalini R, Kim HS, Samson SL (2010) Ectopic corticotropin-releasing hormone (CRH) syndrome from metastatic small cell carcinoma: a case report and review of the literature. Diagn Pathol 5:56","journal-title":"Diagn Pathol"},{"key":"46_CR68","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/S0140-6736(00)04172-6","volume":"357","author":"M Boscaro","year":"2001","unstructured":"Boscaro M, Barzon L, Fallo F, Sonino N (2001) Cushing\u2019s syndrome. Lancet 357:783\u2013791","journal-title":"Lancet"},{"key":"46_CR69","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1056\/NEJM199109263251301","volume":"325","author":"EH Oldfield","year":"1991","unstructured":"Oldfield EH, Doppman JL, Nieman LK et al (1991) Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing\u2019s syndrome. N Engl J Med 325:897\u2013905","journal-title":"N Engl J Med"},{"key":"46_CR70","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/0960-0760(95)00044-Z","volume":"53","author":"BL Wajchenberg","year":"1995","unstructured":"Wajchenberg BL, Mendonca B, Liberman B et al (1995) Ectopic ACTH syndrome. J Steroid Biochem Mol Biol 53:139\u2013151","journal-title":"J Steroid Biochem Mol Biol"},{"key":"46_CR71","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1111\/j.1365-2265.1986.tb01667.x","volume":"24","author":"TA Howlett","year":"1986","unstructured":"Howlett TA, Drury PL, Perry L et al (1986) Diagnosis and management of ACTH-dependent Cushing\u2019s syndrome: comparison of the features in ectopic and pituitary ACTH production. Clin Endocrinol (Oxf) 24:699\u2013713","journal-title":"Clin Endocrinol (Oxf)"},{"key":"46_CR72","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.jneuroim.2008.01.007","volume":"195","author":"M Graaf De","year":"2008","unstructured":"De Graaf M, de Beukelaar J, Bergsma J et al (2008) B and T cell imbalances in CSF of patients with Hu-antibody associated PNS. J Neuroimmunol 195:164\u2013170","journal-title":"J Neuroimmunol"},{"key":"46_CR73","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1200\/JCO.1992.10.1.21","volume":"10","author":"FA Shepherd","year":"1992","unstructured":"Shepherd FA, Laskey J, Evans WK, Goss PE, Johansen E, Khamsi F (1992) Cushing\u2019s syndrome associated with ectopic corticotrophin production and small-cell lung cancer. J Clin Oncol 10:21\u201327","journal-title":"J Clin Oncol"},{"key":"46_CR74","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1001\/archinte.1993.00410060054009","volume":"153","author":"L Delisle","year":"1993","unstructured":"Delisle L, Boyer MJ, Warr D, Killinger D, Payne D, Yeoh JL, Feld R (1993) Ectopic corticotropin syndrome and small-cell carcinoma of the lung. Clinical features, outcome, and complications. Arch Intern Med 153:746\u2013752","journal-title":"Arch Intern Med"},{"key":"46_CR75","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1053\/j.semtcvs.2006.08.005","volume":"18","author":"U Morandi","year":"2006","unstructured":"Morandi U, Casali C, Rossi G (2006) Bronchial typical carcinoid tumors. Semin Thorac Cardiovasc Surg 18:191\u2013198","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"46_CR76","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1089\/thy.2005.15.618","volume":"15","author":"SL Barbosa","year":"2005","unstructured":"Barbosa SL, Rodien P, Leboulleux S, Niccoli-Sire P, Kraimps JL, Caron P, Archambeaud-Mouveroux F, Conte-Devolx B, Rohmer V (2005) Ectopic adrenocorticotropic hormone-syndrome in medullary carcinoma of the thyroid: a retrospective analysis and review of the literature. Thyroid 15:618\u2013623","journal-title":"Thyroid"},{"key":"46_CR77","first-page":"523","volume":"14","author":"N Sarid","year":"2012","unstructured":"Sarid N, Osher E, Gat A, Hoffman M, Oster HS (2012) Cushing\u2019s syndrome as a harbinger of relapsed nonsmall cell lung cancer. Isr Med Assoc J 14:523\u2013524","journal-title":"Isr Med Assoc J"},{"key":"46_CR78","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1210\/jc.2006-2573","volume":"92","author":"MA Nauck","year":"2007","unstructured":"Nauck MA, Reinecke M, Perren A, Frystyk J, Berishvili G, Zwimpfer C, Figge AM, Flyvbjerg A, Lankisch PG, Blum WF, Kl\u00f6ppel G, Schmiegel W, Zapf J (2007) Hypoglycemia due to paraneoplastic secretion of insulin-like growth factor-I in a patient with metastasizing large-cell carcinoma of the lung. J Clin Endocrinol Metab 92:1600\u20131605","journal-title":"J Clin Endocrinol Metab"},{"key":"46_CR79","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/1097-0142(19920101)69:1<66::AID-CNCR2820690113>3.0.CO;2-2","volume":"69","author":"MA Dimopoulos","year":"1992","unstructured":"Dimopoulos MA, Fernandez JF, Samaan NA et al (1992) Paraneoplastic Cushing\u2019s syndrome as an adverse prognostic factor in patients who die early with small cell lung cancer. Cancer 69:66\u201371","journal-title":"Cancer"},{"key":"46_CR80","first-page":"42","volume":"85","author":"NJ Sarlis","year":"2000","unstructured":"Sarlis NJ, Chanock SJ, Nieman LK (2000) Cortisolemic indices predict severe infections in Cushing syndrome due to ectopic production of adrenocorticotropin. J Clin Endocrinol Metab 85:42\u201347","journal-title":"J Clin Endocrinol Metab"},{"key":"46_CR81","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1111\/j.1365-2265.1983.tb00025.x","volume":"19","author":"M Small","year":"1983","unstructured":"Small M, Lowe GD, Forbes CD et al (1983) Thromboembolic complications in Cushing\u2019s syndrome. Clin Endocrinol (Oxf) 19:503\u2013511","journal-title":"Clin Endocrinol (Oxf)"},{"key":"46_CR82","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s12020-009-9186-y","volume":"36","author":"D Kastelan","year":"2009","unstructured":"Kastelan D, Dusek T, Kraljevic I et al (2009) Hypercoagulability in Cushing\u2019s syndrome: the role of specific haemostatic and fibrinolytic markers. Endocrine 36:70\u201374","journal-title":"Endocrine"},{"key":"46_CR83","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1210\/jc.2009-0290","volume":"94","author":"B Zaane Van","year":"2009","unstructured":"Van Zaane B, Nur E, Squizzato A et al (2009) Hypercoagulable state in Cushing\u2019s syndrome: a systematic review. J Clin Endocrinol Metab 94:2743\u20132750","journal-title":"J Clin Endocrinol Metab"},{"key":"46_CR84","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1530\/EJE-09-0627","volume":"163","author":"L Guignat","year":"2010","unstructured":"Guignat L, Bertherat J (2010) The diagnosis of Cushing\u2019s syndrome: an Endocrine Society Clinical Practice Guideline: commentary from a European perspective. Eur J Endocrinol 163:9\u201313","journal-title":"Eur J Endocrinol"},{"key":"46_CR85","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1210\/jc.2008-0125","volume":"93","author":"LK Nieman","year":"2008","unstructured":"Nieman LK, Biller BM, Findling JW, Newell-Price J, Savage MO, Stewart PM, Montori VM (2008) The diagnosis of Cushing\u2019s syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 93:1526\u20131540","journal-title":"J Clin Endocrinol Metab"},{"key":"46_CR86","doi-asserted-by":"publisher","first-page":"211","DOI":"10.7326\/0003-4819-116-3-211","volume":"116","author":"MR Flack","year":"1992","unstructured":"Flack MR, Oldfield EH, Cutler GB, Zweig MH, Malley JD, Chrousos GP, Loriaux DL, Nieman LK (1992) Urine free cortisol in the high-dose dexamethasone suppression test for the differential diagnosis of the Cushing syndrome. Ann Intern Med 116:211\u2013217","journal-title":"Ann Intern Med"},{"key":"46_CR87","first-page":"647","volume":"19","author":"J Newell-Price","year":"1998","unstructured":"Newell-Price J, Trainer P, Besser M, Grossman A (1998) The diagnosis and differential diagnosis of Cushing\u2019s syndrome and pseudo-Cushing\u2019s states. Endocr Rev 19:647\u2013672","journal-title":"Endocr Rev"},{"key":"46_CR88","doi-asserted-by":"publisher","first-page":"434","DOI":"10.7326\/0003-4819-76-3-112-6-434","volume":"112","author":"TB Kaye","year":"1990","unstructured":"Kaye TB, Crapo L (1990) The Cushing syndrome: an update on diagnostic tests. Ann Intern Med 112:434\u2013444","journal-title":"Ann Intern Med"},{"key":"46_CR89","first-page":"440","volume":"84","author":"C Invitti","year":"1999","unstructured":"Invitti C, Pecori Giraldi F, de Martin M, Cavagnini F (1999) Diagnosis and management of Cushing\u2019s syndrome: results of an Italian multicentre study. Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis. J Clin Endocrinol Metab 84:440\u2013448","journal-title":"J Clin Endocrinol Metab"},{"key":"46_CR90","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s11154-010-9139-z","volume":"11","author":"KI Alexandraki","year":"2010","unstructured":"Alexandraki KI, Grossman AB (2010) The ectopic ACTH syndrome. Rev Endocr Metab Disord 11:117\u2013126","journal-title":"Rev Endocr Metab Disord"},{"key":"46_CR91","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1210\/jcem.84.4.5576","volume":"84","author":"DJ Torpy","year":"1999","unstructured":"Torpy DJ, Chen CC, Mullen N, Doppman JL, Carrasquillo JA, Chrousos GP, Nieman LK (1999) Lack of utility of (111)In-pentetreotide scintigraphy in localizing ectopic ACTH producing tumors: follow-up of 18 patients. J Clin Endocrinol Metab 84:1186\u20131192","journal-title":"J Clin Endocrinol Metab"},{"key":"46_CR92","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1002\/1097-0142(19940301)73:5<1361::AID-CNCR2820730509>3.0.CO;2-J","volume":"73","author":"FA Collichio","year":"1994","unstructured":"Collichio FA, Woolf PD, Brower M (1994) Management of patients with small cell carcinoma and the syndrome of ectopic corticotropin secretion. Cancer 73:1361\u20131367","journal-title":"Cancer"},{"key":"46_CR93","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/cncr.23542","volume":"113","author":"BI Gustafsson","year":"2008","unstructured":"Gustafsson BI, Kidd M, Chan A et al (2008) Bronchopulmonary neuroendocrine tumors. Cancer 113:5\u201321","journal-title":"Cancer"},{"key":"46_CR94","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1053\/j.ro.2005.01.001","volume":"40","author":"MB Beasley","year":"2005","unstructured":"Beasley MB, Brambilla E, Travis WD (2005) The 2004 World Health Organization classification of lung tumors. Semin Roentgenol 40:90\u201397","journal-title":"Semin Roentgenol"},{"key":"46_CR95","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1097\/JTO.0b013e3181861d7b","volume":"3","author":"E Lim","year":"2008","unstructured":"Lim E, Goldstraw P, Nicholson AG et al (2008) Proceedings of the IASLC International Workshop on Advances in Pulmonary Neuroendocrine Tumors 2007. J Thorac Oncol 3:1194\u20131201","journal-title":"J Thorac Oncol"},{"issue":"Suppl 2","key":"46_CR96","doi-asserted-by":"publisher","first-page":"S69","DOI":"10.1093\/annonc\/12.suppl_2.S69","volume":"12","author":"E Seregni","year":"2001","unstructured":"Seregni E, Ferrari L, Bajetta E et al (2001) Clinical significance of blood chromogranin A measurement in neuroendocrine tumours. Ann Oncol 12(Suppl 2):S69\u2013S72","journal-title":"Ann Oncol"},{"key":"46_CR97","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/S0889-8529(18)30382-7","volume":"18","author":"LK Kvols","year":"1989","unstructured":"Kvols LK (1989) Therapy of the malignant carcinoid syndrome. Endocrinol Metab Clin North Am 18:557\u2013568","journal-title":"Endocrinol Metab Clin North Am"},{"key":"46_CR98","doi-asserted-by":"publisher","first-page":"R173","DOI":"10.1530\/ERC-17-0036","volume":"24","author":"GK Dimitriadis","year":"2017","unstructured":"Dimitriadis GK et al (2017) Paraneoplastic endocrine syndromes. Endocr Relat Cancer 24:R173\u2013R190","journal-title":"Endocr Relat Cancer"},{"issue":"1","key":"46_CR99","first-page":"00004","volume":"1","author":"H Ahmadieh","year":"2015","unstructured":"Ahmadieh H, Arabi A (2015) Endocrine paraneoplastic syndromes: a review. Endocrinol Metab Int J 1(1):00004","journal-title":"Endocrinol Metab Int J"},{"key":"46_CR100","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/S0889-8529(18)30203-2","volume":"21","author":"G Faglia","year":"1992","unstructured":"Faglia G, Arosio M, Bazzoni N (1992) Ectopic acromegaly. Endocrinol Metab Clin N Am 21:575\u2013595","journal-title":"Endocrinol Metab Clin N Am"},{"key":"46_CR101","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.athoracsur.2007.06.072","volume":"85","author":"S Biswal","year":"2008","unstructured":"Biswal S, Srinivasan B, Dutta P, Ranjan P, Vaiphei K, Singh RS, Thingnam SS (2008) Acromegaly caused by ectopic growth hormone: a rare manifestation of a bronchial carcinoid. Ann Thorac Surg 85:330\u2013332","journal-title":"Ann Thorac Surg"},{"key":"46_CR102","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/0002-9343(78)90827-6","volume":"65","author":"SA Metz","year":"1978","unstructured":"Metz SA, Weintraub B, Rosen SW et al (1978) Ectopic secretion of chorionic gonadotropin by a lung carcinoma. Pituitary gonadotropin and subunit secretion and prolonged chemotherapeutic remission. Am J Med 65:325\u2013333","journal-title":"Am J Med"},{"key":"46_CR103","doi-asserted-by":"publisher","first-page":"920","DOI":"10.7326\/0003-4819-109-11-920","volume":"109","author":"W Hunstein","year":"1988","unstructured":"Hunstein W, Trumper LH, Dummer R et al (1988) Glucagonoma syndrome and bronchial carcinoma. Ann Intern Med 109:920\u2013921","journal-title":"Ann Intern Med"},{"key":"46_CR104","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1001\/archinte.158.12.1381","volume":"158","author":"L Hocqueloux","year":"1998","unstructured":"Hocqueloux L, Mortier E, Cabane J (1998) Pseudopheochromocytoma : an unrecognized cancer-associated syndrome. Arch Intern Med 158:1381\u20131382","journal-title":"Arch Intern Med"},{"key":"46_CR105","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1053\/gast.2001.23242","volume":"120","author":"A Abou-saif","year":"2001","unstructured":"Abou-saif A, Lei J, McDonald TJ et al (2001) A new cause of Zollinger-Ellison syndrome: non-small cell lung cancer. Gastroenterology 120:1271\u20131278","journal-title":"Gastroenterology"}],"container-title":["Hormones"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s42000-018-0046-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-018-0046-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-018-0046-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T23:24:35Z","timestamp":1562023475000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s42000-018-0046-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,2]]},"references-count":105,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["46"],"URL":"https:\/\/doi.org\/10.1007\/s42000-018-0046-0","relation":{},"ISSN":["1109-3099","2520-8721"],"issn-type":[{"value":"1109-3099","type":"print"},{"value":"2520-8721","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,2]]},"assertion":[{"value":"5 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}